ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Onboarding (Day One) | March 2023-Management of Anti-Thrombotic Agents for Patients Undergoing GI Endoscopy

Video Transcription

Video Summary

In this video, the speaker discusses the bleeding risk associated with endoscopic procedures, patient risk factors for bleeding, antithrombotic agents, and national guidelines. The speaker highlights that around 40% of adults in the US take antithrombotic medications for cardiovascular conditions, and the rate of GI bleed in cardiac patients increases with age. The number of ED visits for GI bleeding has also increased in recent years. The speaker emphasizes the need for careful evaluation of the risk and benefits of discontinuing antithrombotics prior to endoscopy, and the importance of multidisciplinary management, guideline-based care, and informed consent. The speaker references several guidelines, including those from the American College of Gastroenterology and the Canadian Association of Gastroenterology. The speaker also discusses bleeding risks associated with different endoscopic procedures and provides recommendations for holding or continuing antithrombotic medications based on the nature of the procedure and the patient's individual risk factors. The speaker concludes by discussing strategies for managing patients who are at high risk and cannot discontinue antithrombotic therapy, as well as approaches for urgent endoscopic procedures in patients with life-threatening GI bleeds. The video provides information for healthcare professionals involved in performing or preparing patients for endoscopic procedures and highlights the importance of a patient-centered multidisciplinary approach. No credits are mentioned in the video.

Asset Subtitle

Sarah Enslin, PA-C

Keywords

bleeding risk

endoscopic procedures

patient risk factors

antithrombotic agents

national guidelines